Source: Health Canada shortage reports · Updated Jul 23, 2026
Cefepime is in a widespread shortage in Canada. 2 of 3 reported products are affected. The latest manufacturer estimate for full recovery is Sep 11, 2026.
A cephalosporin antibiotic given by injection to treat serious bacterial infections.
Products affected
2 / 3
In shortage since
Aug 23, 2012
Est. full return
Sep 11, 2026
Reports on file
18
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
APO-CEFEPIME
1G · POWDER FOR SOLUTION · APOTEX INC
DIN 02467496 · since Jul 21, 2026, est. end Sep 11, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-CEFEPIME
1G · POWDER FOR SOLUTION · APOTEX INC
DIN 02467496 · since May 12, 2026, est. end May 29, 2026 · Disruption of the manufacture of the drug.
Active shortage
CEFEPIME FOR INJECTION
2G · POWDER FOR SOLUTION · APOTEX INC
DIN 02319039 · since Aug 23, 2012, no end estimate · Disruption of the manufacture of the drug.
Resolved
APO-CEFEPIME
2G · POWDER FOR SOLUTION · APOTEX INC
DIN 02467518 · ended Sep 18, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-CEFEPIME
1G · POWDER FOR SOLUTION · APOTEX INC
DIN 02467496 · ended Feb 13, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-CEFEPIME
1G · POWDER FOR SOLUTION · APOTEX INC
DIN 02467496 · ended Nov 7, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-CEFEPIME
2G · POWDER FOR SOLUTION · APOTEX INC
DIN 02467518 · ended Aug 15, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-CEFEPIME
2G · POWDER FOR SOLUTION · APOTEX INC
DIN 02467518 · ended Jun 20, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-CEFEPIME
1G · POWDER FOR SOLUTION · APOTEX INC
DIN 02467496 · ended Jun 20, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-CEFEPIME
2G · POWDER FOR SOLUTION · APOTEX INC
DIN 02467518 · ended Feb 29, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-CEFEPIME
1G · POWDER FOR SOLUTION · APOTEX INC
DIN 02467496 · ended Feb 7, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-CEFEPIME
1G · POWDER FOR SOLUTION · APOTEX INC
DIN 02467496 · ended Aug 23, 2022 · Disruption of the manufacture of the drug.
Showing 12 of 18 reports. All reports are on file with Health Canada.
What's happening
Cefepime is currently affected by 2 active shortage reports filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Cefepime is classified under “OTHER BETA-LACTAM ANTIBACTERIALS” (ATC J01DE).
Recent changes
Jul 23, 2026
New report filed
Common questions
What is Cefepime used for?
A cephalosporin antibiotic given by injection to treat serious bacterial infections.
When will Cefepime be back in stock in Canada?
The latest manufacturer estimate is Sep 11, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Cefepime in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.